CD19+CD27-CD21-CD38- (% Pos of B)

Elevated CD19+CD27-CD21-CD38- B cells, often referred to as "atypical B cells," can have various implications depending on the context. These cells are part of the B-cell population and are characterized by the absence of CD27, CD21, and CD38 markers.

1. Infection and Immune Response: Elevated levels of atypical B cells can sometimes indicate an ongoing immune response to infections or diseases. These cells may be mobilized to help combat pathogens.

2. Autoimmune Disorders: Atypical B cells have been associated with autoimmune disorders, such as common variable immune deficiency (CVID). In CVID, the presence of CD19+CD27-CD21-CD38- B cells is one of the diagnostic criteria.

3. Lymphoma: In some cases, an increase in these atypical B cells may also be observed in lymphoma affecting B cells.

Note: It's crucial to interpret these results in the context of your specific medical history and symptoms. Elevated levels of these cells alone do not provide a definitive diagnosis but may signal the need for further evaluation by a healthcare professional. Discuss these results with your doctor to determine the appropriate follow-up and any necessary diagnostic tests or treatments.

Naive B cells CD19+CD27-CD21-CD38- are a specific subset of B cells with distinct surface marker characteristics:

• CD19+: This marker indicates that these cells express the CD19 antigen, which is commonly found on B cells.

• CD27-: The absence of CD27 expression suggests that these B cells are not memory B cells. CD27 is typically expressed on memory B cells.

• CD21-: The absence of CD21 expression may indicate that these B cells have reduced levels of complement receptor 2 (CR2), which can affect their ability to respond to complement-mediated signals.

• CD38-: The absence of CD38 expression suggests that these B cells have lower levels of CD38, which is involved in various B cell functions, including activation and differentiation.